Custos decorrentes de eventos adversos a medicamento em pacientes hospitalizados
Nenhuma Miniatura disponível
Data
2018-04-05
Autores
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Federal de Goiás
Resumo
Theoretical Background: The adverse drug event (ADE) may occur due to adverse reaction and
medication error. Damage caused by adverse events (AD) can lead to increased hospitalization
time, rehospitalization, greater morbidity, the need for diagnostic and therapeutic interventions,
irreversible consequences such as death and great economic impact. Objective: This study aims to
analyze the costs of adverse drug events in hospitalized patients. Methods: This is a retrospective
study carried out in a public hospital in the state of Goiás, Brazil, with patients admitted to the
adult hospitalization clinics in the year 2016 and who suffered ADE. The colection of data
occurred between May and October 2017. The data were collected through a nursing record and
patient records. Additional hospitalization time, hours worked by the health professional,
therapeutic and diagnostic procedures, and resources used by these users related to ADE were
analyzed. In case of death, the average annual salary was calculated by the years of lost work lives
for the society. The costs of the materials were obtained through a bidding system and the cost
accounting unit of the hospital itself, the Federal Government Price Panel, and procedures through
the SIGTAP Table. The data was typed in the Excel worksheet and analyzed by simple statistics.
The present study was submitted and approved in the ethics committee with protocol in GEP / HC /
UFG nº 030/2017 and was followed what is recommended by Resolution 466/2012. Results: We
identified 164 cases of medication errors and adverse reactions in the nursing records. However,
only the cases of patients in which the medical record was reported and that additional intervention
were included in the study, which totaled 80 cases, 25 of which could have been avoided. The total
costs due to EAM identified in the study were R $ 96,877.90. There were direct costs totaling R $
26,463.90, of which R $ 20,430.36 was obtained from the hospital's perspective and R $ 6,033.54
from the SUS perspective. And of this amount R $ 14,380.13 was due to non-preventable EAM
and R $ 12,083.77 due to preventable EAM. In the perspective of society, there were indirect costs
of R $ 70,414.00, due to the death due to medication failure. Conclusion: It is concluded that the
financial impact requires attention of managers, in the sense that avoiding such costs, it opens up
possibilities for new investments.
Descrição
Citação
NASCIMENTO, L. C. Custos decorrentes de eventos adversos a medicamento em pacientes hospitalizados. 2018. 118 f. Dissertação (Mestrado em Assistência e Avaliação em Saúde) - Universidade Federal de Goiás, Goiânia, 2018.